{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:01:41Z","timestamp":1781204501027,"version":"3.54.1"},"reference-count":34,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T00:00:00Z","timestamp":1089849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Conflicting data have been reported concerning the relationship between <jats:italic>Helicobacter pylori<\/jats:italic> infection and coronary heart disease.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To evaluate clotting system activation and plasma levels of tumour necrosis factor\u2010<jats:italic>\u03b1<\/jats:italic>, a procoagulant cytokine, in patients with <jats:italic>H. pylori<\/jats:italic>\u2010positive and \u2010negative gastritis.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002Three groups of patients were identified: 38 with <jats:italic>H. pylori<\/jats:italic>\u2010positive gastritis, 18 with <jats:italic>H. pylori<\/jats:italic>\u2010negative gastritis, and 40 <jats:italic>H. pylori<\/jats:italic>\u2010negative controls with normal gastric mucosa. Plasma levels of prothrombin fragment 1\u2003+\u20032 (F1\u2003+\u20032) and tumour necrosis factor\u2010<jats:italic>\u03b1<\/jats:italic> were assayed. Patients were also controlled after 2 and 6\u2003months following standard <jats:italic>H. pylori<\/jats:italic> eradication treatment.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002At baseline, fragment 1\u2003+\u20032 and tumour necrosis factor\u2010<jats:italic>\u03b1<\/jats:italic> levels in <jats:italic>H. pylori<\/jats:italic>\u2010positive patients were significantly higher than those in <jats:italic>H. pylori<\/jats:italic>\u2010negative patients with gastritis (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05 and <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01, respectively). After <jats:italic>H. pylori<\/jats:italic> eradication, fragment 1\u2003+\u20032 and tumour necrosis factor\u2010<jats:italic>\u03b1<\/jats:italic> levels showed a significant decrease at 2\u2003months (<jats:italic>P<\/jats:italic>\u2003=\u20030.03 and <jats:italic>P<\/jats:italic>\u2003=\u20030.02, respectively) and a further reduction at 6\u2003months, reaching levels observed in <jats:italic>H. pylori<\/jats:italic>\u2010negative patients and controls.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002The increase thrombin generation rate and the correlation of plasma fragment 1\u2003+\u20032 and tumour necrosis factor\u2010<jats:italic>\u03b1<\/jats:italic> levels in <jats:italic>H. pylori<\/jats:italic>\u2010positive patients suggest a role for inflammation in mediating the relationship between <jats:italic>H. pylori<\/jats:italic> infection and activation of the clotting system.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02074.x","type":"journal-article","created":{"date-parts":[[2004,7,26]],"date-time":"2004-07-26T11:43:37Z","timestamp":1090842217000},"page":"289-294","source":"Crossref","is-referenced-by-count":23,"title":["Increased thrombin generation and circulating levels of tumour necrosis factor\u2010<i>\u03b1<\/i> in patients with chronic <scp>Helicobacter pylori<\/scp>\u2010positive gastritis"],"prefix":"10.1111","volume":"20","author":[{"given":"A.","family":"Consolazio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Borgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Iacopini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. A.","family":"Paoluzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Crispino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Paoluzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,7,15]]},"reference":[{"key":"e_1_2_10_2_2","first-page":"437","article-title":"Relation of Helicobacter pylori infection and coronary heart disease","volume":"71","author":"Mendall MA","year":"1994","journal-title":"BMJ"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7138.1130"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.319.7218.1157"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.74.5.497"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.11.2844"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.163.3.740"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.1.152.152"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.1.128.bloodjournal721128"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V74.1.165.165"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90342-9"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199006073222302"},{"key":"e_1_2_10_13_2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood.V70.2.343.343","article-title":"The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation","volume":"70","author":"Bauer KA","year":"1987","journal-title":"Blood"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.12.1473"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.6.739"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1081\/IPH-100102563"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)92007-6"},{"key":"e_1_2_10_18_2","first-page":"200","volume-title":"Statistical Methods in Medical Research","author":"Armitage P","year":"1990"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.212_a.x"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005522624004"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(98)00256-3"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.93.12.2121"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.1.61"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(98)00130-8"},{"key":"e_1_2_10_25_2","first-page":"301","article-title":"Elevated thrombotic activity after myocardial infarction: a 2\u2010year follow\u2010up study","volume":"28","author":"Martinez\u2010Sales V","year":"1998","journal-title":"Haemostasis"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113238"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(02)00043-6"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.17.1675"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.84.3.267"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.88.1.43"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.76.4.305"},{"key":"e_1_2_10_32_2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","article-title":"A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians","volume":"268","author":"Stampfer MJ","year":"1992","journal-title":"JAMA"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112519"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.13.9.1327"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118771"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02074.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02074.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02074.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:38:24Z","timestamp":1697229504000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02074.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,15]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02074.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02074.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,15]]}}}